BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 413675)

  • 1. [Relationship between suppression of growth hormone by CB-154 and prolactin secretion in acromegaly--indication for a long term care].
    Hara I; Kataoka K; Tomita A; Kuwayama A; Kageyama N
    Horumon To Rinsho; 1977 Dec; 25(12):1316-20. PubMed ID: 413675
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of CB-154 in acromegaly].
    Ishibashi M; Yamaji T
    Horumon To Rinsho; 1977 Dec; 25(12):1292-6. PubMed ID: 598022
    [No Abstract]   [Full Text] [Related]  

  • 3. [Long-term administration of CB-154 in acromegaly].
    Kanezuka H; Makino E; Matsushima Y; Osegawa M; Yamamoto A
    Horumon To Rinsho; 1977 Dec; 25(12):1282-5. PubMed ID: 598020
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug therapy: Bromocriptine.
    Parkes D
    N Engl J Med; 1979 Oct; 301(16):873-8. PubMed ID: 384250
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of dopaminergic stimulation on growth hormone and prolactin in the treatment of acromegaly].
    Nedvídková J; Felt V
    Vnitr Lek; 1980 Oct; 26(10):988-93. PubMed ID: 7467150
    [No Abstract]   [Full Text] [Related]  

  • 6. Superiority of bromocriptine over pyridoxine in the treatment of patients with acromegaly or galactorrhea.
    Blum I; Segal S; Kaufman H; Sagiv M; Shalit M; Chowers I
    Isr J Med Sci; 1980 Jan; 16(1):12-6. PubMed ID: 7188934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long-term use of parlodel in acromegaly].
    Pisarskaia IV; Zefirova GS; Ibragimova GV
    Ter Arkh; 1984; 56(10):107-10. PubMed ID: 6523351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of CB-154 on acromegaly].
    Kato Y; Iwasaki Y; Chihara K; Imura H
    Horumon To Rinsho; 1977 Dec; 25(12):1332-6. PubMed ID: 598038
    [No Abstract]   [Full Text] [Related]  

  • 9. The value of plasma prolactin levels in the prediction of the responsiveness of growth hormone secretion to bromocriptine and TRH in acromegaly.
    Lamberts SW; Liuzzi A; Chiodini PG; Verde S; Klijn JG; Birkenhäger JC
    Eur J Clin Invest; 1982 Apr; 12(2):151-5. PubMed ID: 6807686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of acute parlodel load on the prolactin and STH content in patients with various neuroendocrine diseases].
    Mel'nichenko GA; Bol'shakova TD; Gitel' EP; Langner TK; Barkova MV
    Probl Endokrinol (Mosk); 1983; 29(1):19-23. PubMed ID: 6682222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effects of somatostatin in acromegaly].
    Schaison G; Roger M; Milhaud G
    Nouv Presse Med; 1976 Mar; 5(10):629-32. PubMed ID: 772591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of CB 154 in the treatment of acromegaly in France (author's transl)(proceedings)].
    Bricaire H
    Ann Endocrinol (Paris); 1976; 37(4):305-8. PubMed ID: 1037363
    [No Abstract]   [Full Text] [Related]  

  • 13. Bromocriptine therapy in patients with acromegaly: effects on growth hormone, somatomedin A and prolactin.
    Werner S; Hall K; Sjöberg HE
    Acta Endocrinol Suppl (Copenh); 1978; 216():199-206. PubMed ID: 347862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term therapy of acromegaly and gigantism by using CB-154].
    Aizawa T; Tawada M; Koizumi Y; Ikejiri K; Kotani M
    Horumon To Rinsho; 1977 Dec; 25(12):1310-5. PubMed ID: 598032
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of somatostatin in patients with acromegaly: suppression of growth hormone, prolactin, insulin and glucose levels.
    Yen SS; Siler TM; DeVane GW
    N Engl J Med; 1974 Apr; 290(17):935-8. PubMed ID: 4593614
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of CB-154 (2-Br-alpha-ergocryptine) on prolactin and growth hormone release in an acromegalic patient with galactorrhea.
    Ueda G; Sato Y; Yamasaki M; Shioji T; Aono T
    Endocrinol Jpn; 1975 Jun; 22(3):265-8. PubMed ID: 1242128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of CB-154 administration in acromegaly].
    Nakagawa K; Obara T
    Horumon To Rinsho; 1977 Dec; 25(12):1274-6. PubMed ID: 598017
    [No Abstract]   [Full Text] [Related]  

  • 18. No effect of bromocriptine in acromegaly: a controlled trial.
    Lindholm J; Riishede J; Vestergaard S; Hummer L; Faber O; Hagen C
    N Engl J Med; 1981 Jun; 304(24):1450-4. PubMed ID: 7015129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy of acromegaly using bromocriptine].
    Köbberling J; Schwinn G; Dirks H
    Dtsch Med Wochenschr; 1975 Jul; 100(29):1540-2. PubMed ID: 1149634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of bromocriptine (CB-154) in diabetes associated with acromegaly].
    Sakai Y; Nagasaka A; Makino H
    Horumon To Rinsho; 1977 Dec; 25(12):1323-6. PubMed ID: 598034
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.